Genotype imputation has been widely adopted in the postgenome-wide association studies (GWAS) era. Owing to its ability to accurately predict the genotypes of untyped variants, imputation greatly boosts variant density, allowing fine-mapping studies of GWAS loci and large-scale meta-analysis across different genotyping arrays. By leveraging genotype data from 90 whole-genome deeply sequenced individuals as the evaluation benchmark and the 1000 Genomes Project data as reference panels, we systematically examined four important issues related to genotype imputation practice. First, in a study of imputation accuracy, we found that IMPUTE2 and minimac have the best imputation performance among the three popular imputing software evaluated and that using a multipopulation reference panel is beneficial. Second, the optimal imputation quality cutoff for removing poorly imputed variants varies according to the software used. Third, the major contributing factors to consistently poor imputation are low variant heterozygosity, high sequence similarity to other genomic regions, high GC content, segmental duplication and being far from genotyping markers. Lastly, in an evaluation of the imputability of all known GWAS regions, we found that GWAS loci associated with hematological measurements and immune system diseases are harder to impute, as compared with other human traits. Recommendations made based on the above findings may provide practical guidance for imputation exercise in future genetic studies.
INTRODUCTION
Genotype imputation is used to predict the genotypes at untyped positions in a study cohort based on the genotypes from reference panels. As imputation enables the evaluation of genetic variants that are not directly genotyped, it has become a widely popular tool to boost the power of genetic studies of human traits [1, 2] . There are two common scenarios in which imputation is applied. One is to carry out imputation across the whole human genome to identify novel susceptibility loci [3] [4] [5] . This scenario makes possible the meta-analysis of genome-wide association studies (GWAS) from different genotyping platforms and thus significantly increases the sample size and statistical power [4, 5] . The other scenario is to fine-map known susceptibility loci. In this scenario, imputation provides much denser genetic markers of the corresponding loci and increases the likelihood of identifying causal variants or variants with larger effect sizes [6] [7] [8] [9] [10] [11] [12] .
Building on the international HapMap Project, the 1000 Genomes Project has recently become the dominant choice for imputation reference panels. By taking advantage of the next-generation sequencing technology, the 1000 Genomes Project provides an unprecedentedly deeper catalog of human genetic variants [13, 14] . Specifically, $40 million human genetic variants in 1092 individuals from 14 different populations have been characterized [13] . Although this resource greatly boosts the power and resolution of imputation, it also imposes new challenges to imputation software in terms of the computational burden and reference diversity [15, 16] . As a result, new strategies and algorithms have been applied to improve the imputation software. Although there have been studies investigating imputation accuracy using the 1000 Genomes reference panel [13, 15, [17] [18] [19] , these studies have not intended to compare different imputation programs and therefore only applied one method [13, 15, 17, 19] , have restricted imputation assessment on a single chromosome [17, 18] , have assessed imputation performance without a benchmark of known variant genotypes [17, 19] or have relied on genotypes from genotyping chips as the benchmark for calculating imputation accuracy and therefore have overlooked rare variants [18] .
The purpose of our study is to systematically assess imputation performance using haplotypes from the 1000 Genomes Project as the reference panels by taking advantage of the comprehensive variant genotypes from whole-genome sequencing (WGS). Specifically, we set out to address four important questions: What is the best imputation approach? What cutoff should be used to reliably remove poorly imputed variants? Why are some genomic regions intrinsically difficult to impute? How would that difficulty affect fine-mapping studies of GWAS loci of various human traits? We used genotypes of both single nucleotide variants (SNVs) and small insertions and deletions (INDELs) from the deep WGS of 90 Europeanancestry individuals to assess the performance of three popular imputation software (BEAGLE [20] , IMPUTE2 [15, 16, 21] and minimac [15] ) and two different reference panel settings (singlepopulation versus multi-population reference panel). We also comprehensively examined the contributing factors to poor imputability in specific genomic regions, and we evaluated the imputablity differences between the GWAS loci of various human traits. We anticipate our results will have important implications for future genetic studies using imputation.
MATERIALS AND METHODS Study subjects
The receipt and use of all samples for this research study were approved by the Duke University Health System Institutional Review Board. All subjects provided written informed consent before study participation.
Sequencing and variant calling
The genomic DNA of 90 individuals of European ancestry was whole-genome sequenced using the Illumina Genome Analyzer IIx or the HiSeq 2000. The mean coverage per sample ranged between 30Â and 46Â with an average of 37Â. Raw sequence reads were aligned to the reference genome (NCBI build 37) using Burrows-Wheeler Aligner [22] . After PCR duplicate removal using Picard [23] , we used the Genome Analysis Toolkit (GATK) [24] to generate high-quality variant calls. When no variant call was made at a particular position for a sample, we assumed the genotype to be homozygous reference if the position was covered by no less than 10 reads and no greater than 500 reads (Supplementary Methods); otherwise, the genotype was considered missing. Redundant INDELs were merged together, and their nomenclatures were ensured to be consistent with INDELs from the 1000 Genomes Project using an in-house program called Variant-Matcher (Han et al., unpublished). Variants that overlapped with each other were removed from further analysis, as were monomorphic variants, variants with missing rate >10% and variants that violated HardyWeinberg equilibrium (HWE) (P-value 1e-6). These variant genotypes generated by GATK from the WGS data were considered as known genotypes to be used for evaluating imputation performance. We acknowledge that the genotypes in our benchmark are not 100% accurate. Although recent studies have shown the genotype calling from WGS to be highly sensitive and accurate [25, 26] , there still exist a small amount of genotype errors.
Imputation
SNVs on the Illumina 1M-Duo BeadChip were extracted from the WGS data of the 90 individuals, and 930 560 SNVs with a minor allele frequency (MAF) ! 1% in this study population were used as the genotyped markers to infer untyped markers by imputation. The filtering of genotyped markers here is consistent with real imputation studies where genotyped markers with low MAF, high missing rate and violation of HWE were excluded from GWAS data [the missing rate and HWE filters were already applied in our benchmark (see above)]. We are aware that the sample size of 90 individuals is relatively modest for an accurate estimation of population MAF at the lower end. The only purpose of using MAF here is for filtering out rare genotyped markers, and we found that 98.95% of the 930 560 genotyped markers after the MAF filtering remained the same when using MAF from the 379 individuals of European population in the 1000 Genomes project, indicating reliable performance for filtering genotyped markers by MAF estimated in our data. Illumina 1M-Duo BeadChip is a commonly used genotyping platform in GWAS with decent genome-wide coverage. It contains all content of Illumina610, 85% and 79% of the content in Illumina660W and IlluminaOmniExpress, respectively; therefore, it can be a good representative of multiple platforms. We evaluated the performance of three popular imputation tools (BEAGLE, IMPUTE2 and minimac). To speed up wholegenome imputation from a large reference panel like the 1000 Genomes Project, IMPUTE2 and minimac prephase individuals in the study population using MACH and SHAPEIT, respectively, before imputation [15] . Minimac is a computationally efficient implementation of MACH algorithm that works with prephased halplotypes. Minimac uses a hidden Markov model (HMM) to estimate the marginal probability of unobserved allele in each haplotype in the study population based on the sampled reference haplotypes. These allelic probabilities are then converted to the probabilities of unobserved genotypes in each study individual by assuming HWE [15, 27] . IMPUTE2 also uses HMM, but the parameters of HMM in IMPUTE2 are fixed estimates from fine-scale recombination map and population genetics theory instead of being estimated from the sampled reference haplotypes as in minimac [15, 21] . BEAGLE infers haplotype phase and imputes missing genotype in a unified framework. It fits a HMM model with all markers to all individuals including both the study population and individuals in the reference panel. The posterior genotype probabilities are the sum of the probabilities of the HMM states that correspond to the possible genotypes for a marker [20] . More detailed descriptions of the imputation tools can be found in the respective original publications.
We used two different reference panels for imputation. The 'ALL' panel includes 1092 individuals from all 14 populations in the 1000 Genomes Project, while the 'EUR' panel includes only the 379 individuals from the European population. We split each chromosome into 5 Mb chunks. Chunks at the end of each chromosome arm may be shorter than 5 Mb or may harbor a small number of genotyping markers (<200), in which case we merged the corresponding chunk with its neighboring chunk. We performed imputation within each chunk with a buffer region of 250 kb on either side of the chunk.
Before we evaluated the imputation accuracy, we removed variants residing in regions where genotype calling from sequencing data is less reliable (data not shown). These regions include microsatellites, tandem repeats located by Tandem Repeats Finder [28] , 1 kb regions around assembly gaps and repeats belonging to the 'simple repeat', 'low complexity', 'acro' and 'telo' families as annotated by RepeatMasker [29] . The coordinates of these regions were obtained from the UCSC genome browser [30] .
Simple random sampling
Random sampling was used to generate imputed SNVs and INDELs with matching MAF distribution within the same MAF category. The MAF used in this analysis was estimated using the 379 individuals of European population in the 1000 Genomes Project. From the imputed variants in each of the three MAF categories [rare (MAF < 1%), lowfrequency (1% MAF < 5%) and common (MAF ! 5%)], we randomly drew 25 000 SNVs and 25 000 INDELs without replacement and only kept this random sampling when the MAF distribution was similar between the SNVs and the INDELs (Kolmogorov-Smirnov test P-value > 0.05). We repeated the process to obtain 1000 sets of SNVs and INDELs, which were used to confirm that the differences in imputation accuracy observed between SNVs and INDELs within each MAF category were not driven by their MAF distribution difference.
Low imputability regions
To identify the genomic regions that are intrinsically difficult to impute, we first pooled different groups of imputed variants from their corresponding best imputation approach to form the most accurate collection of imputed variants. Specifically, we obtained the imputation results of rare SNVs from 'minimac_ALL', rare INDELs from 'BEAGLE _ALL', low-frequency variants from 'IMPUTE2 _ALL', common SNVs from 'minimac_EUR' and common INDELs from 'BEAGLE_ALL'. The low imputability regions were then defined based on the three criteria: (i) containing at least two imputed variants, (ii) the average R 2 of imputed variants is 0.4 and (iii) no imputed variants have R 2 > 0.5.
Factors contributing to low imputability
Information about factors contributing to low imputability was obtained as described below. The recombination rate, conservation and mappability values and the coordinates of segmental duplications, repeats and structural variants were obtained from the UCSC genome browser. The recombination rate used is the calculated deCODE recombination rate. The conservation score corresponded to the primate phastCons score for conservation. For variants spanning >1 bp, the mean phastCons score was used. The mappability corresponded to the alignability of 100mers by the GEM (GEnome Multitool)-mappability program from ENCODE/CRG (up to two mismatches were allowed). The repeats were identified by RepeatMasker, and the structural variants were those annotated by the Database of Genomic Variants [31] . The GC content was calculated as the percentage of G or C in a region of the reference genome that is within 50 bp of each variant. We calculated three different statistics to represent the marker density of each variant: the distance to the nearest genotyped marker and the number of genotyped markers within 5 and 2.5 kb of the variant. A homopolymer is defined as a single nucleotide repeat with a minimal length of six in the reference genome.
Imputability score
We downloaded the imputability scores of variants in the 1000 Genomes Project calculated by Duan et al from the 1000G Marker Imputability Database (http://www.unc.edu/$yunmli/1000G-imp/ download.php).
Association between low imputability regions and GWAS loci of various human traits
The mapping between each trait category and individual GWAS, as well as the coordinates of the corresponding GWAS hits, were obtained from the NHGRI GWAS catalog Web site [32, 33] . A GWAS locus was defined as the 100 kb intervals centered on each GWAS hit. Fisher's exact test was used to test among all of the imputed variants whether those in low imputability regions were significantly enriched in the GWAS loci of each trait category as compared with the GWAS loci of the other traits. When calculating the fraction of imputed variants falling into low imputability regions for each GWAS locus, we merged the overlapping loci corresponding to the same disease category into a single one before calculation.
RESULTS

Evaluation of imputation accuracy
The first question we address here is what the best imputation approach is for populations of European ancestry. To impute more variants in European populations, one could impute either directly from the European reference panel ('EUR') or from a reference panel containing all populations ('ALL'). We compared six imputation approaches composed of three widely used programs (BEAGLE, IMPUTE2 and minimac) and two different reference panels ('EUR' and 'ALL'). The criteria used to evaluate the imputation performance were the percentage of variants that were accurately imputed [squared correlation between known genotypes from the WGS data and imputed allele dosages (R 2 ) > 0.8], and only those variants present in the European population were used for evaluation.
Based on the overall imputation performance (Table 1 and Figure 1 ), we found that minimac and IMPUTE2 performed similarly, and both were better than BEAGLE. The speed of the two programs was also superior to BEAGLE The percentage of variants that are imputed to be monomorphic and therefore their corresponding R 2 are NA. These variants were treated as R 2 ¼ 0 when evaluating imputation performance.
(Supplementary Table S1 ). In addition, using a reference panel containing diverse populations resulted in slightly better (or comparable) performance than using a reference panel from the same population as the study cohort. Compared with the other two imputation programs, IMPUTE2 is more likely to make monomorphic imputations, where the imputed genotypes were homozygous of the same allele among all individuals.
We then evaluated the imputation performance separately by variant type (SNVs versus small INDELs) as well as by MAF (Table 2 and Figure 2 ). We used MAF estimated from the EUR population in the 1000 Genomes Project for separating imputed variants. For rare variants (MAF < 1%), we found that imputation using the 'ALL' reference panel is clearly better than when using the 'EUR' reference panel for each software. These differences decrease as the variants become more common. For variants with a MAF of at least 5% in the population, there is little difference in the performance between the two different reference panels. When using the 'ALL' reference panel, we did not observe clear differences in terms of the software performance for INDEL imputations within any MAF category, but for rare and low-frequency (1% MAF < 5%) SNVs, we found the performance of BEAGLE to be inferior to those of the other two programs (Figure 2 ). Interestingly, we found that rare INDELs can be more accurately imputed than can rare SNVs. This trend starts to flip when the variants become more common. For common variants (MAF ! 5%), the imputation of SNVs is much better than is the imputation of INDELs. To confirm that the performance differences we observed between SNVs and INDELs within each MAF category were not driven by their MAF distribution difference, we performed 1000 randomizations where the MAF distribution of SNVs and INDELs were kept the same (see 'Materials and Methods' section). Consistent with the initial results, we observed that rare INDELs were significantly better imputed than were rare SNVs, while imputing INDELs in the other two MAF categories was significantly less accurate than was imputing SNVs, regardless of the 2 with the known genotypes are greater than the corresponding cutoff value on the x-axis. The gray dashed line corresponds to an R 2 cutoff 0.8. The solid lines corresponds to the six imputation approaches using one of the three imputation programs (BEAGLE, IMPUTE2 and minimac) and one of the two reference panels ('EUR' and 'ALL'). A colour version of this figure is available at BIB online: http://bib.oxfordjournals.org. 554 Table S2 ).
Comparing imputation quality measure
Each imputation tool studied here provides an estimate of the imputation accuracy for each imputed variant, which can be used as a guide for the quality of the imputed variants in reality. Therefore, it is important to know how well these imputation quality measures reflect the true imputation quality R 2 . The allelic R 2 from BEAGLE is the squared correlation between the best-guess genotype and the allele dosage. The information metric from IMPUTE2 measures the relative statistical information about the population allele frequency. The minimac Rsq is the ratio of the observed variance of the allele dosage to the expected binomial variance at HWE. Despite differences in the calculation of these imputation quality measures (reviewed by Marchini and Howie [2] ), they all range between 0 and 1, with larger values corresponding to higher imputation quality. As shown in Table 3 , our results indicated that for each tool, the quality measure from imputation using the 'ALL' reference panel correlates with the R 2 equal to or slightly better than the values from using the 'EUR' reference panel. The allelic R 2 from BEAGLE does not correlate with R 2 as strongly as the quality measures from the other two programs. The percentage of invalid quality measure values is also much higher with BEAGLE.
Investigators usually rely on the imputation quality measure to remove poorly imputed variants from further analysis. Therefore, we also evaluated the performance of using those imputation quality measures in removing poorly imputed variants (R 2 < 0.5).
As in reality imputed variants with invalid imputation quality measures will be eliminated from the later association tests, we treated these variants as having imputation quality measures of zero in our analysis of the accuracy of removing poorly imputed variants. We noticed that in this setting, the quality measure of BEAGLE is comparable with (or even slightly better than) the quality measures from the other two programs in removing poorly imputed variants from their corresponding imputation results (Figure 3 ). For BEAGLE, the accuracy of removing poorly imputed variants generally decreases as the imputation quality cutoff increases. For minimac, the accuracy first increases as the quality measure cutoff increases but decreases when the cutoff value becomes large (e.g. >0.6). For IMPUTE2, the accuracy of removing poorly imputed variants peaks at large cutoff values (e.g. 0.8). Therefore, to achieve the highest accuracy, we recommend setting the imputation quality cutoff to small values for BEAGLE (e.g. <0.4), intermediate values for minimac (e.g. between 0.2 and 0.6) and large values for IMPUTE2 (e.g. between 0.6 and 0.9).
Identification of low imputability regions and the contributing factors
Although it is natural to speculate that there may be regions in the genome that are intrinsically difficult to make accurate imputations due to, for example, frequent recombination, the factors that contribute to the low imputability have not previously been systematically investigated. The identification of these factors will improve our understanding of imputation and will allow us to develop better strategies to enhance imputation performance. To identify these low imputability regions, we first combined the imputation results from the corresponding best performing approach for different variant groups to generate the most accurate imputation results (see 'Materials and Methods' section). We then scanned through these imputed variants for low imputability regions meeting the following three criteria: (i) containing at least two imputed variants, (ii) the average R 2 of imputed variants is 0.4 and (iii) no imputed variants have R 2 > 0.5. This process identified 184 516 low imputability regions.
We further investigated what factors contribute to the low imputability of those regions. Multivariate logistic regression was used to determine the effect of a number of possible contributing factors on whether an imputed variant is in a low imputability region, Invalid values of the imputation quality measure were considered to be zero. A colour version of this figure is available at BIB online: http://bib.oxfordjournals.org.
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which included allele composition and violation of HWE in the study cohort, recombination, GC content, conservation, marker density, mappability and special genomic regions including segmental duplications, repeat masker regions, structural variants and homopolymers. For some factors that can be represented by multiple statistics, such as allele composition and marker density, we chose the best representative statistic with the lowest Akaike information criterion (AIC) in univariate logistic regression with low imputability (Supplementary Table  S3 ). The top five factors with the largest effects on imputability are allele composition (observed heterozygosity), mappability, GC content, segmental duplication and marker density (distance to the closest marker) ( Figure 4A and Supplementary Table S4 ).
Variants with low heterozygosity, low mappability, high GC content, within segmental duplication regions or far from genotyped markers are more likely to fall into low imputability regions. Recently, Duan et al have computed the so-called 'imputability scores' for variants from the 1000 Genomes Project [34] . The scores are R 2 values between the imputation dosages and real genotypes when imputing each individual in the 1000 Genomes Project while using the remaining individuals as the reference panel. To confirm our findings, we used the imputability scores calculated with the same population and genotyping platform as our study population and repeated the above analysis to define the low imputability regions and investigate the contributing factors to low imputability. Based on the lowest AIC in univariate logistic regression, we obtained the same sets of representative statistics (Supplementary Table S5 ). We then included these statistics as covariates to represent all of the contributing factors in a multivariate logistic regression model. Consistent with our findings, we identified the same five factors (observed heterozygosity, segmental duplication, GC content, marker density and mappability) as the largest contributors to the low imputability (Supplementary Figure S1 and Supplementary  Table S6 ).
Low imputability regions and GWAS loci
Imputation has been widely used to fine-map GWAS loci [1] [2] [3] 17] . Causal variants or stronger association signals have been reported in the finemapping studies of diverse GWAS [6] [7] [8] [10] [11] [12] . To evaluate whether imputation works equally well in fine-mapping GWAS loci of different traits, we studied the association between the low imputability regions and the known GWAS loci of 13 trait categories extracted from 1122 GWAS studies (see 'Materials and Methods' section). Our results indicated that, compared with other traits, the GWAS loci for hematological measurements and immune system diseases are significantly enriched with low imputability regions (Table 4 ). This result suggests that using imputation to fine-map the GWAS signals of those traits may not work as well as the other traits, as there are more difficult-to-impute regions in those loci. On the other hand, the GWAS loci of seven trait categories, including nervous system disease, biological process, body measurement and response to drug are significantly depleted for low imputability regions as compared with the other traits, suggesting that fine-mapping these GWAS loci using imputation is more likely to be successful. To confirm our observation is not mainly driven by a few complex loci, such as the MHC region, we calculated the fraction of imputed variants inside low imputability regions in each locus and compared the distribution of the fraction among different trait categories. Consistently, we found higher proportion of GWAS loci from immune system disease and hematological measurement in particular have larger fraction of imputed variants inside low imputability regions (Table 4 and Supplementary Figure S2 ).
DISCUSSION
As an important approach to boost the power of genetic studies of human traits, imputation has been widely adopted in the post GWAS era. By using the genotypes from 90 whole-genome deepsequenced individuals as the benchmark, we systematically assessed the imputation performance of three popular imputation tools and two different reference panels from the 1000 Genomes Project. Our results addressed four important questions that are often encountered in imputation-based genetic studies:
What is the best imputation approach? Based on the overall performance we observed, IMPUTE2 and minimac can make more accurate imputations than BEAGLE, and using a multi-population reference panel is more beneficial than is using a single-population reference panel, even if this population is the same as the study cohort. This trend gets stronger as variants become rarer in the population, especially Figure 4 : The factors contributing to low imputability. Low imputability was defined based on R 2 from our imputation results. The P-values (A) and coefficients (B) from multivariate logistic regression of low imputability were shown. Only the covariates with P-value < 0.05 in the multivariate logistic regression are shown. The covariates are ordered by increasing P-value and then by decreasing magnitude of coefficients. Repeat families are represented by the white bars, and the remaining covariates are represented by the gray bars.
for SNVs. Interestingly, we found that rare INDELs can be better imputed than rare SNVs, but this trend flipped when the variants become common. We speculate that the difference between INDELs and SNVs in imputation performance is likely driven by the variant quality difference between them. Lu et al. has reported potential ascertainment bias of INDELs in the 1000 Genomes data in that low frequency INDELs were more enriched with small INDELs while common INDELs were more enriched with large INDELs [35] . Owing to the limitation of short read sequencing and INDEL calling algorithms, accurate genotype calls for large INDELs in individual samples is challenging. In addition, as variants become common, it is more difficult to consolidate genotypes across samples for INDELs than SNVs because of the flexible nature of INDELs (multi-allele and various length). We speculate that both factors may impair the genotype accuracy for common INDELs and therefore lessen the improvement in imputation accuracy as variant frequency increases.
What cutoff should be used to reliably remove poorly imputed variants? The optimal cutoff for the imputation quality measure depends on the specific software used for imputation, which is affected by both the imputation accuracy of the software and the accuracy of the quality measure used by the software. Why are some genomic regions intrinsically difficult to impute? We noticed that there are regions of the human genome where variant imputation is consistently poor. We sought to identify the factors that contribute to the low imputability in these regions and revealed that low variant heterozygosity, high sequence similarity to other regions, high GC content, segmental duplication and being far from genotyping markers are the five major factors that result in poor imputation in these regions. The recombination rate is generally considered to be an important factor in imputation. Although it is still a significant contributing factor, the recombination rate is not among the top five contributing factors. Instead, mappability has a bigger impact on imputability. The lower the mappability, the greater the number of locations to which the particular sequence can be mapped in the genome. As a result, low mappability will likely decrease the genotype accuracy of the markers genotyped based on probe hybridization, as will decrease the genotype accuracy in the sequencing-based reference panel and in our benchmark, leading to lower imputation accuracy. In addition, the MAF is well-known to affect imputation, but we found that variant heterozygosity is a better predictor of imputability than MAF (Supplementary Table  S3 ), suggesting that not only the rareness of a variant matters but also the variant's zygosity status. For imputation studies using preexisting GWAS data, not much can be done to enhance the imputation accuracy in these low imputability regions other than The fraction of imputed variants in GWAS loci of other trait categories that fall inside low imputability regions. The proportion GWAS loci within each trait category with >6% of imputed variants falling inside low imputability regions.
using a better reference panel, as the genotyping markers were already set. For other imputation studies where investigators can select the genotyping markers for imputation (such as fine-mapping studies of specific loci), instead of focusing only on linkage disequilibrium, there are additional important factors that must be taken into account when selecting genotyping markers. Incorporating more low heterozygosity markers and markers in high GC areas and increasing marker density will likely improve the imputation accuracy in these hard-to-impute regions. These observations also have implications for array manufacturers to design a new generation of genotyping arrays such that imputation accuracy at the low imputability regions can be increased when using the genotype data from these new arrays.
How would low imputability affect fine-mapping studies of GWAS loci? In our analysis of the overlap between low imputability regions and GWAS loci from 13 trait categories, variants in low imputability regions are found to be significantly enriched in GWAS loci of hematological measurements and immune system diseases as compared with other trait categories. This finding suggests that special attention should be paid when fine-mapping the GWAS loci of these two traits because imputation is intrinsically harder in these loci. Genes involved in host-pathogen interactions in human are known to be under positive selection to confer protection from pathogen infection. These genes not only include the immune response genes but also include genes expressed on the blood cell surface, as they can be used as gateways for pathogen to enter into human cells [36] . On the other hand, we noticed the GWAS loci of hematological measurements and immune system diseases are more rapidly evolving than are loci from other trait categories (Supplementary Figure S3) . Therefore, we speculate that the enrichment of low imputability regions we observed in the above two trait categories could be attributed to both the positive selection and the fast evolution acting on these loci, which likely affect the corresponding genomic context and reshape the local linkage disequilibrium structure. Therefore, it is critical to assess the variant imputability in the loci to be fine-mapped beforehand, especially the GWAS loci of hematological measurements and immune system diseases that were observed to be more significantly overlapped with low imputability regions than other traits. The recent availability of the 1000G Marker Imputability Database [34] has provided a public resource to assess imputability. When the imputability of the variants in the loci are low, denser genotyping and more careful selection of markers (as described above) will help to achieve better results in the fine-mapping studies of these loci.
With the continued expansion of the 1000 Genomes data, more and more imputation-based genetic studies will be carried out to take advantage of this rich resource. Comparing with previous studies that also assessed imputation performance using 1000 Genomes haplotypes [13, 15, [17] [18] [19] , our study has a number of advantages: more imputation strategies were evaluated; the power for assessing imputation accuracy, particularly for rare variants, is greatly improved by using genotypes from the largest number of WGS benchmark samples to date; imputation to whole-genome instead of restricting to a single chromosome allows the first genome-wide assessment of imputation patterns such as the factors contributing to low imputability and the imputation performance difference in GWAS discovered loci of various human traits. We anticipate that the findings from our systematic evaluation of imputation performance will facilitate the design and application of future imputation-based genetic studies. Although the largest sample size of WGS data used for imputation evaluation to date, 90 individuals is still limited in power for assessing rare variants (e.g. MAF < 1%). In our future studies, we will apply the best imputation approach identified in this study to evaluate imputation performance of using different genotyping platforms and other sequencing-based reference panels based on many more wholegenome sequenced samples.
SUPPLEMENTARY DATA
Supplementary data are available online at http:// bib.oxfordjournals.org/.
Key Points
IMPUTE2 and minimac can make more accurate imputations, and using a multi-population reference panel is more beneficial than is using a single-population reference panel.
The optimal imputation quality cutoff for removing poorly imputed variants depends on the imputation software used. The major contributing factors to consistently poor imputation are low variant heterozygosity, high sequence similarity to other genomic regions, high GC content, segmental duplication and being far from genotyping markers. GWAS loci associated with hematological measurements and immune system diseases are harder to impute, as compared with other human traits.
